Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
作者信息
Ampofo William K, Baylor Norman, Cobey Sarah, Cox Nancy J, Daves Sharon, Edwards Steven, Ferguson Neil, Grohmann Gary, Hay Alan, Katz Jacqueline, Kullabutr Kornnika, Lambert Linda, Levandowski Roland, Mishra A C, Monto Arnold, Siqueira Marilda, Tashiro Masato, Waddell Anthony L, Wairagkar Niteen, Wood John, Zambon Maria, Zhang Wenqing
机构信息
National Influenza Centre, Accra, Ghana.
Food and Drug Administration, Rockville, MA, USA.
出版信息
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2(Suppl 2):52-53. doi: 10.1111/irv.12081.
Abstract
摘要
相似文献
1
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.改进流感疫苗病毒的选择：2010年6月14日至16日在瑞士日内瓦世界卫生组织总部举行的世卫组织非正式磋商会报告
Influenza Other Respir Viruses. 2013 Sep;7 Suppl 2(Suppl 2):52-53. doi: 10.1111/irv.12081.
2
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.改进流感疫苗病毒选择：世卫组织于 2010 年 6 月 14 日至 16 日在瑞士日内瓦世卫组织总部举行的一次世卫组织非正式磋商的报告。
Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8.
3
Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.加强流感疫苗病毒的选择与研发过程：2014年4月1 - 3日于瑞士日内瓦世界卫生组织总部举行的第三次世卫组织改进流感疫苗病毒选择非正式磋商会报告
Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090. Epub 2015 Jul 3.
4
Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011.加强流感疫苗病毒的选择与研发过程：2011年12月7日至9日在瑞士日内瓦国际会议中心举行的第二届世界卫生组织改进流感疫苗病毒选择非正式磋商会的成果
Vaccine. 2013 Jul 11;31(32):3209-21. doi: 10.1016/j.vaccine.2013.05.049. Epub 2013 May 17.
5
The evolving history of influenza viruses and influenza vaccines.流感病毒和流感疫苗的演进史。
Expert Rev Vaccines. 2013 Sep;12(9):1085-94. doi: 10.1586/14760584.2013.824709. Epub 2013 Sep 12.
6
Influenza Virus: Dealing with a Drifting and Shifting Pathogen.流感病毒：应对一种不断漂移和变异的病原体。
Viral Immunol. 2018 Mar;31(2):174-183. doi: 10.1089/vim.2017.0141. Epub 2018 Jan 26.
7
Influenza: Can we cope better with the unpredictable?流感：我们能否更好地应对不可预测的情况？
Hum Vaccin Immunother. 2016 Mar 3;12(3):699-708. doi: 10.1080/21645515.2015.1086047.
8
Influenza vaccines: challenges and solutions.流感疫苗：挑战与解决方案。
Cell Host Microbe. 2015 Mar 11;17(3):295-300. doi: 10.1016/j.chom.2015.02.012.
9
Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.为具有不同暴露前病史的人群选择季节性流感疫苗毒株的挑战。
Curr Opin Virol. 2014 Oct;8:85-9. doi: 10.1016/j.coviro.2014.07.007. Epub 2014 Aug 11.
10
Influenza virus surveillance among young children in São Paulo, Brazil: the impact of vaccination.巴西圣保罗幼儿中的流感病毒监测：疫苗接种的影响
Braz J Microbiol. 2014 Oct 9;45(3):1113-5. doi: 10.1590/s1517-83822014000300047. eCollection 2014.
引用本文的文献
1
Uncovering the Burden of Influenza-Associated Illness across Levels of Severity in the Kingdom of Saudi Arabia Across Three Seasons.揭示沙特阿拉伯王国三个季节中不同严重程度的流感相关疾病负担。
J Epidemiol Glob Health. 2025 Mar 20;15(1):47. doi: 10.1007/s44197-025-00390-1.
2
Reduction of Influenza A Virus Prevalence in Pigs at Weaning After Using Custom-Made Influenza Vaccines in the Breeding Herds of an Integrated Swine Farm System.在一体化养猪场系统的种猪群中使用定制流感疫苗后，断奶仔猪甲型流感病毒流行率降低。
Viruses. 2025 Feb 10;17(2):240. doi: 10.3390/v17020240.
3
A broad-spectrum vaccine candidate against H5 viruses bearing different sub-clade 2.3.4.4 HA genes.一种针对携带不同2.3.4.4亚分支HA基因的H5病毒的广谱候选疫苗。
NPJ Vaccines. 2024 Aug 19;9(1):152. doi: 10.1038/s41541-024-00947-4.
4
Predictive evolutionary modelling for influenza virus by site-based dynamics of mutations.基于突变位点动力学的流感病毒预测进化建模。
Nat Commun. 2024 Mar 21;15(1):2546. doi: 10.1038/s41467-024-46918-0.
5
Antigenic characterization of influenza and SARS-CoV-2 viruses.流感病毒和 SARS-CoV-2 病毒的抗原特征。
Anal Bioanal Chem. 2022 Apr;414(9):2841-2881. doi: 10.1007/s00216-021-03806-6. Epub 2021 Dec 14.
6
Vaccine development lessons between HIV and COVID-19.艾滋病病毒与新冠病毒疫苗研发的经验教训
Lancet Infect Dis. 2021 Jun;21(6):759-761. doi: 10.1016/S1473-3099(21)00274-7.
7
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity.流感疫苗的佐剂化以诱导交叉保护性免疫。
Vaccines (Basel). 2021 Jan 21;9(2):75. doi: 10.3390/vaccines9020075.
8
Influenza passaging annotations: what they tell us and why we should listen.流感传代注释：它们告诉了我们什么以及为何我们应该倾听。
Virus Evol. 2019 Jun 30;5(1):vez016. doi: 10.1093/ve/vez016. eCollection 2019 Jan.
9
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.微型血凝素疫苗接种可在预先接触过的非人灵长类动物中诱导产生交叉反应性抗体，从而保护小鼠免受致命性流感攻击。
NPJ Vaccines. 2018 Jul 3;3:25. doi: 10.1038/s41541-018-0063-7. eCollection 2018.
10
Reverse Genetics Approaches for the Development of Influenza Vaccines.用于流感疫苗研发的反向遗传学方法。
Int J Mol Sci. 2016 Dec 22;18(1):20. doi: 10.3390/ijms18010020.
Zotero 插件